This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignee: Teijin Pharma Limited. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Brett Michael Johnson: Innovator in Pharmaceutical Chemistry
Introduction
Brett Michael Johnson is a notable inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzimidazole derivatives.
Latest Patents
Johnson holds a patent for "Benzimidazole derivatives and their uses." This invention provides compounds that inhibit the activity of TRPC6, along with pharmaceutically acceptable salts, pharmaceutical compositions, methods for manufacturing these compounds, and their therapeutic uses. His work is crucial in advancing medical treatments and therapies.
Career Highlights
Brett Michael Johnson is associated with Teijin Pharma Limited, where he applies his expertise in pharmaceutical development. His career reflects a commitment to innovation and the advancement of healthcare solutions.
Collaborations
Johnson has collaborated with notable colleagues, including Laurie B Schenkel and Nagasree Chakka. These partnerships enhance the research and development efforts within his field.
Conclusion
Brett Michael Johnson's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a key inventor in the industry. His work continues to impact the development of therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile